Xentria, Inc.
Clinical trials sponsored by Xentria, Inc., explained in plain language.
-
New insulin put to the test against humalog in healthy volunteers
Knowledge-focused CompletedThis study compared a new insulin called NKF-INS(L) with two approved versions of Humalog (US and EU) in 54 healthy men. The goal was to see if the new insulin is absorbed and works similarly in the body. Participants received a single dose of each insulin in random order, and th…
Phase: PHASE1 • Sponsor: Xentria, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC
-
New insulin put to the test in healthy men
Knowledge-focused CompletedThis study checked if a new insulin aspart (NKF-INS(A)) is similar to two already-approved insulins (US-NovoLog and EU-NovoRapid). It involved 54 healthy adult men who received a single dose of each insulin in a random order. Researchers used a special technique to measure how th…
Phase: PHASE1 • Sponsor: Xentria, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC